Dylan Coronado
Pharmacogenomic testing for SSRIs analyzes CYP2C19 and CYP2D6 genes to predict how your body metabolizes antidepressants. This can prevent severe side effects by matching drug choice and dose to your genetics.
Mar 14 2025
Dec 4 2025
Mar 12 2026
Dec 2 2025
Mar 4 2026